Final guidance on US FDA's expedited access plan for devices in FY 2015
This article was originally published in SRA
Executive Summary
Device companies interested in the US Food and Drug Administration's new voluntary program for faster evaluation of certain high-risk devices for unmet medical needs can hope to get a clearer picture of the initiative when the agency issues final guidance on this topic in fiscal year 20151.
You may also be interested in...
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Regulators Explain How To Ensure Transitioned Trials Align With CTR
Members of the EU’s Clinical Trials Coordination Group have developed harmonized requirements for updating trials that are transitioned to the Clinical Trials Information System based on a minimum set of documents.
Global Medtech Guidance Tracker: March 2024
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Fifty-nine documents have been posted on the tracker since its last update.